Načítá se...
Corticosteroids for the treatment of Kawasaki disease in children
BACKGROUND: Kawasaki disease (KD), or mucocutaneous syndrome, is the leading cause of childhood‐acquired heart disease in the developed world. There is much controversy on how best to treat children with KD and in particular who may benefit from additional treatment beyond the standard intravenous i...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2017
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464937/ https://ncbi.nlm.nih.gov/pubmed/28129459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011188.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|